Amniotics AB (publ) (AMNI.ST)

SEK 0.01

(5.88%)

Operating Income Summary of Amniotics AB (publ)

  • Amniotics AB (publ)'s latest annual operating income in 2023 was -29.07 Million SEK , up 37.74% from previous year.
  • Amniotics AB (publ)'s latest quarterly operating income in 2023 FY was -34.01 Million SEK , up 27.16% from previous quarter.
  • Amniotics AB (publ) reported an annual operating income of -46.69 Million SEK in 2022, up 9.54% from previous year.
  • Amniotics AB (publ) reported an annual operating income of -51.61 Million SEK in 2021, down -66.53% from previous year.
  • Amniotics AB (publ) reported a quarterly operating income of -7.51 Million SEK for 2023 Q4, down -24.68% from previous quarter.
  • Amniotics AB (publ) reported a quarterly operating income of -11.3 Million SEK for 2023 Q1, down -21.55% from previous quarter.

Annual Operating Income Chart of Amniotics AB (publ) (2023 - 2018)

Historical Annual Operating Income of Amniotics AB (publ) (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -29.07 Million SEK 37.74%
2022 -46.69 Million SEK 9.54%
2021 -51.61 Million SEK -66.53%
2020 -30.99 Million SEK -197.23%
2019 -10.42 Million SEK -47.11%
2018 -7.08 Million SEK 0.0%

Peer Operating Income Comparison of Amniotics AB (publ)

Name Operating Income Operating Income Difference
Alligator Bioscience AB (publ) -248.98 Million SEK 88.323%
Ziccum AB (publ) -21.56 Million SEK -34.847%
Modus Therapeutics Holding AB (publ) -16.4 Million SEK -77.264%
BioArctic AB (publ) 252.64 Million SEK 111.508%
Sprint Bioscience AB (publ) -845 Thousand SEK -3340.592%
Mendus AB (publ) -100.65 Million SEK 71.115%
Genovis AB (publ.) 54.22 Million SEK 153.616%
Intervacc AB (publ) -93.57 Million SEK 68.932%
QuiaPEG Pharmaceuticals Holding AB (publ) -15.51 Million SEK -87.423%
Active Biotech AB (publ) -46.48 Million SEK 37.456%
Magle Chemoswed Holding AB (publ) 18 Million SEK 261.436%
Bio-Works Technologies AB (publ) -55.41 Million SEK 47.538%
Aptahem AB (publ) -10.1 Million SEK -187.716%
Vicore Pharma Holding AB (publ) -321.5 Million SEK 90.957%
Kancera AB (publ) -65.04 Million SEK 55.301%
Infant Bacterial Therapeutics AB (publ) -134.61 Million SEK 78.403%
Fluicell AB (publ) -26.87 Million SEK -8.163%
Saniona AB (publ) -81.06 Million SEK 64.136%
Lipigon Pharmaceuticals AB (publ) -12.37 Million SEK -135.009%
Biovica International AB (publ) -126.07 Million SEK 76.94%
Spago Nanomedical AB (publ) -42.5 Million SEK 31.601%
AcouSort AB (publ) -17.48 Million SEK -66.255%
Xintela AB (publ) -57.23 Million SEK 49.207%
Abliva AB (publ) -96.54 Million SEK 69.888%
Egetis Therapeutics AB (publ) -324.8 Million SEK 91.049%
Karolinska Development AB (publ) -3.5 Million SEK -729.472%
OncoZenge AB (publ) -15.9 Million SEK -82.826%
2cureX AB (publ) -36.36 Million SEK 20.048%
CombiGene AB (publ) -36.3 Million SEK 19.92%
Asarina Pharma AB (publ) -14.64 Million SEK -98.586%
Calliditas Therapeutics AB (publ) -384.39 Million SEK 92.437%
Camurus AB (publ) 532.35 Million SEK 105.461%
Corline Biomedical AB -1.78 Million SEK -1526.007%
IRLAB Therapeutics AB (publ) -180.76 Million SEK 83.917%
Isofol Medical AB (publ) -41.68 Million SEK 30.252%
I-Tech AB 24.43 Million SEK 218.981%
Hansa Biopharma AB (publ) -788.49 Million SEK 96.313%
Cyxone AB (publ) -21.66 Million SEK -34.218%
ExpreS2ion Biotech Holding AB (publ) -105.96 Million SEK 72.564%
Biosergen AB -27.26 Million SEK -6.631%
Cantargia AB (publ) -290.01 Million SEK 89.975%
NextCell Pharma AB -43.17 Million SEK 32.658%
Xspray Pharma AB (publ) -180.76 Million SEK 83.917%
Elicera Therapeutics AB (publ) -17.09 Million SEK -70.055%
Nanologica AB (publ) -69.96 Million SEK 58.445%
SynAct Pharma AB -224.49 Million SEK 87.05%
Annexin Pharmaceuticals AB (publ) -44.17 Million SEK 34.188%
Stayble Therapeutics AB (publ) -23.95 Million SEK -21.369%
LIDDS AB (publ) -40.67 Million SEK 28.522%
Lipum AB (publ) -37.25 Million SEK 21.96%
BioInvent International AB (publ) -369.94 Million SEK 92.141%
Alzinova AB (publ) -16.52 Million SEK -75.965%
Oncopeptides AB (publ) -253.44 Million SEK 88.529%
Pila Pharma AB (publ) -6.39 Million SEK -354.745%
Guard Therapeutics International AB (publ) -115.07 Million SEK 74.735%
Scandinavian ChemoTech AB (publ) -20.13 Million SEK -44.362%
Simris Alg AB (publ) -36.63 Million SEK 20.641%
Diamyd Medical AB (publ) -146.56 Million SEK 80.164%
Xbrane Biopharma AB (publ) -310.42 Million SEK 90.634%
Ascelia Pharma AB (publ) -110.91 Million SEK 73.788%
Diagonal Bio AB (publ) -11.56 Million SEK -151.366%